Memphasys to launch new device to boost IVF success
Medical technology company Memphasys plans its first commercial sales of its unique Felix medical device to boost success in IVF procedures in the second half of 2020. The Sydney company told investors in a market update that its automated, non-DNA damaging lab instrument for sperm separation was undergoing assessment by a series of key opinion…